A graduate of Birkbeck, University of London’s computer science program, Keyvan Azami currently leads Bloomberg LP’s derivative trading technology and global development team. In his free time Keyvan Azami enjoys active physical pursuits and has supported annual Cycle for Survival events.
Cycle for Survival was co-founded by Jennifer and David Linn in 2007 as a means of raising money to support rare cancer research at New York’s Memorial Sloan Kettering (MSK) Cancer Center. Teams of four raise funds and participate in annual Cycle for Survival events throughout the United States. Each participant is required to ride 50 minutes on a stationary bike and raise a minimum of $1,000.
After a modest first year in 2007 with just 230 cyclists and $250,000 raised for the MSK Cancer Center, Cycle for Survival has grown immensely in recent years; 13 cities held events in 2015, with 21,000 cyclists combining to raise $25 million. Hundreds of cyclists took over Times Square in September of 2016, kicking off the 10th anniversary of Cycle for Survival Rides. By the end of the year $30 million had been raised by participating riders, bringing the total the program has raised for cancer research to $117 million.
Keyvan Azami serves as head of fixed income derivatives trading technology with Bloomberg LP, a software and media company. Outside of work, Keyvan Azami participates in and supports the annual Light the Night Walk benefiting the Leukemia and Lymphoma Society.
As a fundraising event, Light the Night raises money for blood cancer research and provides information and educational materials to patients.
Light the Night Walks take place all over the United States. They reach close to 200 different communities across the country, and each person raises an estimated $250. Participants who raise $1,000 or more become members of Light the Night’s Bright Lights Club. In a show of gratitude, Light the Night offers participants incentives depending on the amount they raised.
To participate, individuals can choose to be either a walker or a sponsor. As a walker, they raise funds, and then join the walk carrying a lighted lantern. Walkers can go alone or in a team. Those who choose not to walk can still support Light the Night by sponsoring a walker.
For more information about joining a Light the Night event, visit registration.lightthenight.org to see a list of participating cities.
Based in New York City, finance professional Keyvan Azami guides the development of derivatives trading and exchange technology at Bloomberg, LP, and international business firm. Away from the office, Keyvan Azami engages in a variety of charitable endeavors, including his involvement with the Leukemia & Lymphoma Society.
For nearly 70 years, the Leukemia & Lymphoma Society (LLS) has operated with a focus on identifying cures for all forms of blood cancer. The organization supports its research and outreach by hosting frequent national events and campaigns, such as the Light the Night Walk.
The Light the Night Walk provides an opportunity for the community of individuals who suffer from leukemia, lymphoma, myeloma, and Hodgkin’s disease and their families to unite across the country. During the walk, participants carry a lantern of one of three colors representing patients, survivors, and those who have lost their lives.
In October 2016, the Light the Night Walk will take place in three of New York City’s Boroughs: Staten Island, Manhattan, and Queens. Registration is open and fundraising efforts have begun; for more information, visit www.lightthenight.org.
Keyvan Azami transferred from Barclay’s Capital in London to the New York City office in 2007 to serve as a vice president and the global head of rates etrading technology. In 2014, he accepted an offer from Bloomberg LP, where he currently heads fixed-income derivatives trading technology. Outside of work, Keyvan Azami enthusiastically supports several charities, particularly Light the Night.
Light the Night is an annual event hosted by the Leukemia and Lymphoma Society to raise awareness of blood cancers, raise funds to fight them through research, and improve quality of life for patients and their families. Generally held in the fall, the walks take place in more than 200 locations throughout the United States, and the society’s chapters in Canada and Australia also sponsor walks.
Everyone is invited to walk – patients, survivors, and their families, friends, and supporters. The walks are generally short and are intended to be completed at a leisurely pace in an hour or less. Walkers are asked to solicit donations for the cause, and those who raise $100 or more receive a t-shirt to wear at the walk, a colored lantern, and a wristband for food. Survivors and current patients receive all three, regardless whether they raise funds or not.
The three-colored lanterns give the event its name. Survivors carry white lanterns, and those who are supporting someone with a blood cancer carry red lanterns. Gold lanterns are carried by those who are walking in memory of a loved one lost to the disease. Light the Night has proven to be a popular and effective event through the years, and in 2014, it raised nearly $19 million to fight blood cancers.
With more than a decade of experience in investment banking front office technology, Keyvan Azami serves as the head of FI Derivatives Electronic Trading technology at Bloomberg LP in New York. Outside of his professional responsibilities, Keyvan Azami supports several charitable initiatives, including the Light the Night annual walk for leukemia and lymphoma.
Each fall in North America and Australia, supporters gather for an evening walk to raise funds and awareness for blood cancers such as leukemia and lymphoma. Neighbors and co-workers form teams to solicit donations, and retail stores often join the cause and also collect donations. Walkers carry lighted lanterns, with survivors carrying white lanterns and supporters carrying red lanterns in the U.S. and blue lanterns in Australia. Those who have lost someone to blood cancer carry gold lanterns. The walking distances vary by community and often depend on local geography.
The funds raised by Light the Night support research efforts, education programs to raise public awareness, and advocacy efforts to ensure access to treatments. Some funds also provide personalized assistance to people with the diseases.
The 2014 Light the Night Walk in Manhattan occurred on September 18. Thousands of people gathered at the intersection of West and Christopher streets and walked south for about a mile, lighting the way with their lanterns. The walk ended at Hudson River Park’s Pier 26. Of the corporate teams, Barclays was the most successful fundraiser with more than double the contributions achieved by the second place team.